CHMP work plan 2024

Letter of support for a composite endpoint method for acceptability evaluation of oral drug formulations in the paediatric population

Paediatric investigation plans: submitting documents

Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes

Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)

CHMP PROM minutes for the meeting on 30 October 2023

International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)

Overview of comments received on ICH reflection paper on proposed international harmonisation of real-world evidence terminology and convergence of general principles regarding planning and reporting of studies using real-world data

Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 27, Status: Authorised

EMA business hours over holiday period